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Abstract
Background: Cholesterol metabolism may be involved in pediatric gallstone disease. We aimed to reveal
cholesterol metabolites and phytosterols and their relation to stone composition of sterols in children having black
pigment and cholesterol stones.
Methods: We performed retrospective controlled clinical study, in which we examined parameters of cholesterol
metabolism and liver function values in serum (n = 28) and gallstones (n = 46) of consecutively cholecystectomized
children. Serum values of age-, body mass index- and sex-matched children (n = 82) and adult gallstones (n = 187)
served as controls.
Results: Surrogate markers of cholesterol synthesis in serum (squalene/cholesterol, cholestenol/cholesterol and
lathosterol/cholesterol) were 26–52 % higher in both stone subclasses compared to controls (p < 0.05 for all).
Respectively, cholestanol/cholesterol and plant sterols campesterol/cholesterol and sitosterol/cholesterol
(cholesterol absorption markers) had decreasing order in serum: black pigment stone group > controls >
cholesterol stone group (p < 0.05 for all). In black pigment stone group, stone cholestanol/cholesterol was
associated with serum bile acids (r = 0.620, p = 0.018). In cholesterol stone group, surrogate markers of cholesterol
synthesis in serum (e.g., lathosterol/cholesterol) inversely reflected those of absorption (r-range -0.633–-0.706,
p-range 0.036–0.015). In cholesterol stone group, serum and stone lathosterol/cholesterol and cholestanol/
cholesterol were positively interrelated (r-range 0.727–0.847, p < 0.05 for both).
Conclusions: Gallstone subclasses shared enhanced cholesterol synthesis. Cholesterol stone children were low
cholesterol absorbers with intact homeostasis of cholesterol metabolism. Black pigment stone group was characterized
by deteriorated cholesterol metabolism, and accumulation of cholestanol, campesterol and sitosterol in serum and
stones suggesting their participation in pathogenesis.
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Background
Gallstones are quite rare in healthy children, but they
more frequently occur in subjects who have a predispos-
ing condition [1, 2]. Recent series document an increasing
incidence of pediatric gallstone disease most probably due
to increased detection with frequent use of ultrasonog-
raphy, as well as the growing obesity epidemic [3]. Grad-
ing of gallstones into black pigment (BPS), brown pigment
(BRPS) and cholesterol stones (CS) can be performed by
determining the stone cholesterol content [4–7]. More
exact classification methods apply ultrastructural examin-
ation with scanning electron microscopy, x-ray diffrac-
tometry and infrared spectroscopy [8].
Numerous conditions have been associated with the
pathogenesis of BPS, in which the elevated biliary bilirubin
level is the cornerstone phenomenon, and this is fre-
quently a consequence of chronic haemolysis or hepato-
biliary disease [2, 6]. In turn, BRPS have been related to
parenteral nutrition even more tightly than the BPS [7].
CS, which are more frequent in older children and adults
than pigment stones (PS), are formed by several patho-
physiologic factors, of which certain properties in choles-
terol metabolism play essential roles. These metabolic
features include hepatic hypersecretion of biliary lipids,
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enhanced phase transition of cholesterol, high efficiency
of intestinal cholesterol absorption and increased hepatic
biosynthesis of cholesterol [9].
Cholesterol homeostasis is maintained by the inter-
action between intestinal absorption, de novo synthesis,
hepatic output into the bile and fecal secretion of choles-
terol [10]. Phytosterols are not synthesized in the human
body, but they are normally absorbed to a much lesser ex-
tent than cholesterol, and, consequently, their serum levels
are only 0.1–0.005 % of total cholesterol concentration
[11]. Of phytosterols in serum, campesterol and sitosterol
are the most abundant ones, whereas stigmasterol and
avenasterol form minor fractions. That ratios to choles-
terol of campesterol, sitosterol and cholestanol (a 5-α sat-
urated, enzymatically formed derivative of endogenous
cholesterol) in serum are associated with the efficiency of
cholesterol absorption among human subjects has been
documented in detail [12–17]. Generally in serum, the ra-
tios to cholesterol of squalene, lanosterol and cholesterol
demethylated precursor sterols, i.e., cholestenol, desmos-
terol and lathosterol, positively reflect cholesterol synthe-
sis and inversely cholesterol absorption efficiency and the
respective surrogate sterol markers of cholesterol absorp-
tion [13–17]. These variables of cholesterol metabolism
occur also in bile and gallstones [5, 7]. Additionally, serum
level of lathosterol reflects the hepatic HMG-CoA reduc-
tase activity [17, 18].
The main focuses of the present study were addressed
to the following questions: 1) is the cholesterol metabol-
ism deteriorated in pediatric BPS and CS patients com-
pared to each other or healthy controls and 2) how the
serum levels of cholesterol and the surrogate markers of
cholesterol metabolism are related to the respective
sterol composition of the gallstones. Thus, we analysed
variables of cholesterol metabolism in serum samples
(n = 28) and gallstones (n = 46) of consecutively chole-
cystectomized pediatric gallstone patients of a tertiary
referral centre, and compared the serum values with
age-, BMI- and sex-matched controls (serum) and the
gallstone values with respective adult ones.
Methods
Patients
Gallstones of consecutively cholecystectomized children
(<19 years old) from April 2004 – to January 2013, and,
respectively, serum samples from January 2009 to January
2013 were retrospectively examined for the purposes of the
present study. Preliminary results of solely the analysed
gallstones of 18 subjects have been reported earlier [7].
Gallstones were identified preoperatively with ultrasonog-
raphy in all patients. In addition, twelve patients underwent
MRI cholangiography. Preoperatively bile duct stones were
detected in five patients, four of whom had removal of
stones by endoscopic sphincterotomy and in one the bile
duct stone passed spontaneously into the duodenum. One
BPS patient and two CS patients belonged to the cohort
with measured composition of sterols in the gallstones.
Two BPS patients belonged the cohort with serum
measurements.
The term idiopathic gallstone disease was defined as oc-
currence of gallstones without any associated disease. Other
diseases were excluded by clinical examination, abdominal
ultrasound and blood samples, which were analysed for
haemoglobin, white and red blood cells, platelets, alkaline
phosphatase (ALP), alanine and aspartate aminotransferases
(ALT and AST, respectively), bile acids, bilirubin, conju-
gated bilirubin, C-reactive protein, glutamyl transferase
(γGT) and sedimentation rate by routine hospital methods.
Patient demographic data was obtained including age, gen-
der, height and weight at admission. Past and present med-
ical history was collected including associated medical
illnesses and medication. The use of parenteral nutrition
was recorded.
The study was performed according to the principles of
the 1975 Declaration of Helsinki (6th revision, 2008). The
study was approved by the Ethics Committee of the Hos-
pital for Children and Adolescents, University of Helsinki.
An informed consent was obtained from parents of each
patient included in the study.
Methods
Fasting serum samples were drawn at the time of the
cholecystectomy. Concentrations of cholesterol, squa-
lene, cholestanol, cholesterol precursor sterols (lanos-
terol, cholestenol, desmosterol and lathosterol), and
plant sterols (campesterol, sitosterol, avenasterol and
stigmasterol) in serum were measured from nonsaponi-
fiable material by gas–liquid chromatography (GLC), on
a 50-m long SE-30 capillary column (Ultra 1 column,
Hewlett-Packard) as described earlier [19, 20]. Serum
total, LDL and HDL cholesterol and serum triglycerides
were analyzed enzymatically using automated analyzer
systems.
During the cholecystectomy, gallstones were collected
from the gallbladder for analysis. Gallstone sterols and
squalene were determined with GLC as described in de-
tail earlier [5, 7] and shortly reviewed here. The gall-
stones were washed with distilled water, dried in a
desiccator and powdered with mortar. The gallstone
pulver (25-100g) was saponified with 2 M KOH in 90 %
ethanol for two hours using 5α-cholestane as an internal
standard. After saponification, aqua was added to
achieve 1:1 (vol/vol) water-ethanol suspension. The
nonsaponifiable lipids were extracted with hexane,
washed once with 50 % ethanol, dissolved twice with
hexan-methanol (2:3 vol/vol), evaporated to dryness and
finally silylated to trimethylsilylethers and quantitated
by GLC.
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Serum levels of bile acids (available in 14 BPS and 10
CS patients), bilirubin, liver enzymes and thromboplastin
time were determined by routine hospital methods prior
to cholecystectomy.
Calculations
Classification of the gallstones into CS, BRPS and BPS
subclasses was performed as described earlier [5, 7].
Stones containing cholesterol less than 35 % of the
stone weight were classified as PS, and greater than
35 % as CS. Based on the cholesterol content, PS were
subdivided into BRPS (containing cholesterol 10 to 35 %
of the stone weight) and BPS (correspondingly less than
10 %). Practically the BRPS subgroup, characterized by
calcium palmitate, included mixed cholesterol gall-
stones and the BPS included the so-called calcium car-
bonate stones [8, 21–23].
The results of three patients with BRPS were published
in our preliminary report [7], and, thus, the BRPS group
was excluded from the present study. The results of the
previously analysed and preliminarily reported [7] gall-
stones of 18 children were combined with respective values
of 28 subjects, who participated the study from January
2009 onwards, because the composition of gallstone sterols
in these two pediatric cohorts were comparable.
To eliminate the effect of varying lipoprotein levels,
serum non-cholesterol sterol values were related to
serum cholesterol and are expressed in terms of 102 ×
mmol/mol of cholesterol of the same GLC run (ratios).
Ratios of surrogate sterol markers of cholesterol synthe-
sis (e.g., lathosterol) to those of cholesterol absorption
(e.g., campesterol) in serum were calculated in order to
evaluate differences in cholesterol metabolism.
The serum variables were compared to an age-, sex- and
BMI- matched control group of 82 subjects, which con-
sisted of healthy day-case surgery patients (i.e., inguinal
hernia, umbilical hernia, undescended testes) without evi-
dence of intestinal disease, diabetes, or dyslipidemia. The
Finnish reference values –based body mass index-for-age
(ISO-BMI) were used for children over two years old [24].
The gallstone variables were compared to the respect-
ive adult values including 178 cholesterol stones (ACS)
and 9 black pigment stones (APS) [5]. In this study, the
term “adult controls” refers to gallstone composition of
cholesterol and non-cholesterol sterols.
In order to standardize the variations, the stone non-
cholesterol sterols were expressed as milligrams by stone
weight and in terms of 102 × mmol of non-cholesterol
sterol /mol of cholesterol (called proportions or ratios in
the text).
Statistical analyses
The data were analysed for significance and normality
with the Number Crunching Statistical Software™ (NCSS™,
Statistical Solutions Ltd., 2007, Kaysville, Utah). Logarith-
mic transforms were calculated for skewed distributions.
Comparisons between gallstone subclasses and controls
were performed with general linear model analysis of vari-
ance using age, ISO-BMIs and gender as covariates. If p-
values were below 0.05, comparison between the groups
were carried out with two-tailed unpaired t-test. Categor-
ical variables were summarized as count and compared
using the chi-squared or Fisher’s exact test where appro-
priate. Correlations were analysed by calculating Pearson’s
correlation test or by Spearman rank correlation test in
case of skewed distributions. The sample sizes for the
study groups were calculated according to the following
hypotheses. Pediatric gallstone sterol compositions differ
by several fold between the pediatric BPS and CS patients
[7]. Thus, it could be estimated that the difference in
serum non-cholesterol sterol ratios (e.g., lathosterol/chol-
esterol and campesterol/cholesterol) is two-fold or more
between BPS and CS patients, and that the differences
from the respective control values is 40 % or more. The
type I error rate and the power of the study were consid-
ered to be 5 % and 80 %, respectively. Consequently, at
least 8 patients in a subgroup were required for the study
using a two-sided test. A p-value <0.05 was considered
significant.
Results
Characteristics of the patients and the gallstones
The whole study group consisted of 46 consecutively
cholecystectomized children (median age 13.5 years;
range 0.2–18.9; median ISO-BMI 21.5 kg/m2; range
14.4–31.0), of whom 31 were female (Table 1, Fig. 1). All
the patients had symptoms related to gallstone disease.
BPS were more abundant in children than in adults
(57 % versus 5 %, p < 0.001). The 26 patients with BPS
(median age 11.9 years; range 0.2–18.9; median ISO-
BMI 19.8 kg/m2; range 14.4–25.5; 15 girls) were on an
average 3 years younger than the 20 CS ones (16 girls),
and, respectively, the median of their ISO-BMI was 26 %
lower (p < 0.05 for both) (Table 1). However, among
those children, who participated in serum analysis (n =
28, 17 girls), gender distribution, age and ISO-BMI were
equal between the stone subclasses and the controls
(Table 1). Analysis of covariance showed that these con-
founding factors did not change the statistically signifi-
cant differences in serum and gallstone values between
the groups reported here. Two patients were Africans,
the other BPS ones were Caucasians.
In the CS-group, most of the gallstones were idiopathic
(70 %), whereas in the BPS-group the etiopathogenesis was
more heterogeneous, and the most common clinical diag-
nosis were haemolytic diseases (38 %) and idiopathic (27 %)
(Table 2). Only four PS patients had a history of parenteral
nutrition. Preoperative serum values of haemoglobin, white
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and red blood cells, platelets, C-reactive protein and sedi-
mentation rate were within normal limits in both sub-
groups of patients (not shown). Preoperative serum levels
of γGT were elevated by 1.6- - 5-fold in 19 % of the patients
with BPS and in 10 % among those with CS (p = 0.33)
(Table 3). The median of total bilirubin level in serum was
two times higher in BPS than in CS (p = 0.02) (Table 3). Re-
spectively, serum levels of ALP were above the upper limit
of normal by 1.1- - 1.3-fold in 8 % (BPS-group) and in 9 %
(CS-group) (p = 1.00).
Table 1 Characteristics of the study patients in whole study group (n = 46)1 and in a subgroup, in which both serum and gallstones
values were analysed (n = 28)
Parameter BPS CS Controls P
Subgroup: serum and gallstones analysed (n = 28)
Subjects n (%) / female n (%) 17(61)/9(53) 11(39)/8(73) 82/37(45) 0.215
Age (years) 10.5 ± 1.6 14.1 ± 2.0 10.7 ± 0.7 0.198
ISO-BMI (kg/m2) 21.3 ± 1.2 25.2 ± 1.4 22.5 ± 0.7 0.085
Whole group: gallstones analysed only (n = 46)
Subjects n (%) / female n (%) 26(57)/15(58) 20(43)/16(80) 187/138(74) 0.386
Age (years) 11.2 ± 0.9* 14.1 ± 0.6 Adults 0.02
ISO-BMI (kg/m2) 20.9 ± 0.9* 25.7 ± 1.1 Adults 0.001
Values are means ± SEM
BPS, black pigment stones, CS cholesterol stones, ISO-BMI age- and sex- matched body mass index
1Preliminary results of gallstone analysis of 18 subjects have been reported earlier [7]
Fig. 1 Columns show distribution of 46 cholecystectomized subjects according to gender and stone cholesterol content. Brown pigment stones
(cholesterol content 10–35 mg/100 mg stone weight) were excluded in the present study
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Of the BPS, 23 % were single, 8 % were multiple and
69 % were microlithiasis. Respective percent values for
CS were 20 %, 25 % and 55 % (p = 0.267).
Of the five patients with bile duct stones, three had
BPS and two had CS. These children had no specific
characteristics in their serum sterol levels or in the com-
position of sterols in the gallstones.
One CS patient was African, one was American In-
dian, but the other CS ones were Caucasians.
Serum concentrations of enzymatic cholesterol,
lipoprotein lipids and bile acids
The mean serum concentrations of lipoprotein lipids and
bile acids were equal between the BPS and CS subclasses.
The respective concentrations (±SEM) were for enzymatic
cholesterol: 3.4 ± 0.3 mmol/l and 4.1 ± 0.3 mmol/l, for
LDL-cholesterol 2.0 ± 0.2 mmol/l and 2.6 ± 0.3 mmol/l,
for HDL-cholesterol 1.2 ± 0.1 mmol/l and 1.4 ± 0.1 mmol/
l, for triglycerides 1.2 ± 0.2 mmol/l and 1.1 ± 0.2 mmol/l
and for bile acids 10 ± 8 μmol/l and 21 ± 10 μmol/l.
Serum levels of squalene, cholesterol and non-cholesterol
sterols
Compared to the control group, the BPS subclass was char-
acterized by 20–106 % higher ratios to cholesterol of squa-
lene, cholestenol, lathosterol and desmosterol (p < 0.05 for
all) (Table 4). Respectively, that of cholestanol was ~11 %
higher, but stigmasterol ~41 % lower than control values
(p < 0.05 for both).
Compared to the control group, the CS subclass also
had high ratios to cholesterol of squalene and choles-
terol precursor sterols excluding desmosterol (21–93 %,
p < 0.05 for all), but low those of cholestanol and plant
sterols (17–41 % below the control values, p < 0.05 for
all) (Table 4).
The differences between the subclasses were 18 %
lower cholesterol concentration, but 31–34 % higher ra-
tios to cholesterol of cholestanol, campesterol and sitos-
terol in the BPS group than in the CS one (p < 0.05 for
all) (Table 4). The ratio to campesterol of lathosterol in
the CS subclass was 3.2-fold (p = 0.010) and 5.5-fold (p
Table 2 Past or present clinical diagnosis in gallstone patients
Diagnosis All BPS CS
n = 46 n = 26 n = 20
Idiopathic gallstones 21 (46) 7 (27) 14 (70)
Hemolytic disease 11 (24) 10 (38) 1 (5)
Neonatal hyperbilirubinemia1 5 (11) 5 (20) -
History of parenteral nutrition 5 (11) 5 (19) -
Inflammatory bowel disease 3 (7) 3 (12) -
Epilepsy with medication 2 (4) - 2 (10)
Extrahepatic portal vein occlusion 2 (4) 1 (4) 1 (5)
Transplanted kidney 2 (4) 2 (8) -
Acute leukemia 1 (2) 1 (4) -
Intestinal failure, transplanted small bowel 1 (2) 1 (4) -
Meningomyelocele 1 (2) - 1 (5)
Neurofibromatosis 1 (2) - 1 (5)
Octreotide treatment, pancreatitis (non biliary) 1 (2) 1 (4) -
Values are n (%)
BPS black pigment stones, CS cholesterol stones
1neonatal hyperbilirubinemia is included in the count of hemolytic disease
Table 3 Preoperative liver biochemistry of gallstone patients
BPS CS p valueb
Patients (n) 26 20
Plasma aspartate aminotransferase (IU/L) 32 (9–122) 22 (17–67) 0.07
n (%)a 2 (8) 2 (10) 1.00
Plasma alanine aminotransferase (IU/L) 22 (12–26) 17 (10–306) 0.43
n (%)a 3 (12) 3 (15) 1.00
Plasma glutamyl transferase (IU/L) 25 (9–55) 19 (13–51) 0.33
n (%)a 5 (19) 2 (10) 0.45
Plasma bilirubin (μmol/L) 11 (6–187) 5 (4–52) 0.02
n (%)a 10 (38) 2 (10) 0.04
Plasma bilirubin, conjugated (μmol/L) 4 (1–10) 2 (1–13) 0.06
n (%)a 2 (8) 1 (5) 1.00
Serum bile acids (μmol/L) 8 (2–32)c 4 (2–151)d 0.75
n (%)a 7 (50) 1 (10) 0.08
Data are median (range)
BPS black pigment stones, CS cholesterol stones
aNumber of patients (percentage) off normal range
bComparison between patient subgroups using Fisher’s exact test or Mann Whitney U-test
cData available in 14 patients
dData available in 10 patients
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< 0.001) higher than in the BPS and the control groups,
respectively (Table 4).
Gallstone sterols and squalene
Compared to the adult controls, the gallstones of the BPS-
group were characterized by 2.0–3.1 –fold higher lanosterol
and desmosterol values (in terms of mmol/mol of choles-
terol) (Table 5). Parallel to that, also plant sterols and cho-
lestanol values were 2.6–3.5 –fold above the controls (p <
0.001 for all) (Table 5).
The respective comparison in the CS-group revealed
that lanosterol and desmosterol were 2.8–4.0 -fold above
the controls (in terms of mmol/mol of cholesterol), and
the relative markers of cholesterol absorption, i.e., cho-
lestanol and campesterol, were 1.5–3.4 –fold higher than
in controls (p < 0.001 for all) (Table 5).
The comparison of the two stone subclasses with each
other showed that the cholesterol content in the BPS stones
(mg/100 mg of stone) was, by definition, ~ 2 % of the CS-
value (p < 0.001) (Table 5). Compared to the CS, in terms of
mmol/mol of cholesterol, the BPS were rich in squalene and
lanosterol, but lathosterol was only 46 % of the CS-value (p
< 0.001 for both). Respectively, plant sterols sitosterol, stig-
masterol and avenasterol, were 3–13 –fold higher in the
BPS-subclass (p < 0.001 for all) (Table 5).
The total absolute amount of stone bile acids in BPS
was double the controls and 4-times above that of CS (p <
0.05 for both) (Table 5).
Table 4 Comparison of serum cholesterol, squalene and
non-cholesterol sterols in patients with gallstones and controls
BPS CS Controls P
(n = 17) (n = 11) (n = 82)
Cholesterol 129 ± 9a 158 ± 9 145 ± 3 0.042
Squalene1 23 ± 2b 28 ± 3c 17 ± 1 0.003
Lanosterol1 8 ± 2 11 ± 1 −2 0.167
Cholestenol1 31 ± 4d 24 ± 5e 15 ± 2 0.010
Lathosterol1 137 ± 17f 168 ± 21g 87 ± 8 0.007
Desmosterol1 107 ± 7h 104 ± 8 86 ± 3 0.035
Cholestanol1 186 ± 9i 126 ± 11j 168 ± 4 <0.001
Campesterol1 312 ± 34k 207 ± 41l 310 ± 15 <0.001
Sitosterol1 170 ± 18m 117 ± 22n 176 ± 8 0.001
Avenasterol1 45 ± 4 40 ± 5o 48 ± 2 0.037
Stigmasterol1 17 ± 3p 17 ± 3q 29 ± 1 <0.001
Lathosterol/Campesterol 0.58 ± 0.19r 1.87 ± 0.68s 0.34 ± 0.02 <0.001
Values are mean ± SEM
BPS black pigment stones, CS cholesterol stones
1100× mmol/mol of cholesterol
2Not determined
aP = 0.045 compared to CS. bP = 0.015 and cP < 0.001 compared to controls.
dP =0.002 and eP = 0.009 compared to controls. fP = 0.006 and gP = 0.029
compared to controls. hP = 0.003 compared to controls. iP < 0.001 compared to
CS and P = 0.007 compared to controls. jP < 0.001 compared to controls.
kP = 0.002 compared to CS and lP < 0.001 compared to controls. mP = 0.006
compared to CS and nP < 0.001 compared to controls. oP = 0.014 compared to
controls. pP < 0.001 and qP = 0.001 compared to controls. rP = 0.010 compared
to CS and sP < 0.001 compared to controls
Table 5 Comparison of gallstone composition of cholesterol, proportions of squalene and non-cholesterol sterols and total bile acids
in black pigment stones (n = 26) and cholesterol stones (n = 20) between pediatric patients and adult controls (n = 187)
Black pigment stones Cholesterol stones P
Children Adult controls Children Adult controls
n = 26 n = 9 n = 20 n = 178
Cholesterol 2 ± 2† 3 ± 1 84 ± 2 83 ± 1 <0.001
Squalene 291 ± 71† - 9 ± 1 - 0.001
Lanosterol 483 ± 21*† 245 ± 45 17 ± 24* 4 ± 1 <0.001
Cholestenol 387 ± 54 118 ± 31 378 ± 61 215 ± 8 <0.001
Lathosterol 956 ± 136† 990 ± 181 2073 ± 155 1915 ± 46 <0.001
Desmosterol 150 ± 769* 48 ± 12 168 ± 876* 60 ± 2 <0.001
Cholestanol 1233 ± 76* 480 ± 68 930 ± 87* 629 ± 22 <0.001
Campesterol 1046 ± 52* 311 ± 60 728 ± 59* 215 ± 8 <0.001
Sitosterol 1343 ± 269*† 389 ± 14 227 ± 307 137 ± 4 <0.001
Stigmasterol 209 ± 64† - 16 ± 73 - <0.001
Avenasterol 323 ± 31† - 94 ± 36 - <0.001
Bile acids 7.5 ± 1.2*† 3.8 ± 1.0 1.9 ± 0.5 0.7 ± 0.1 <0.001
Values are mean ± SEM. Cholesterol and bile acids mg/100 mg of stone. Squalene and non-cholesterol sterols 100 x mmol/mol of cholesterol
*p < 0.05 compared to the respective value in adults
†p < 0.05 compared to the cholesterol stones
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Correlations
The age at the time of the cholecystectomy had practic-
ally no relation to the variables studied here. ISO-BMI
was inversely related to the stone cholestanol proportion
in the CS group only (n = 20, r = −0.586, p = 0.007).
In the patients with BPS, serum cholesterol and non-
cholesterol sterols were poorly interrelated. However,
squalene, the non-sterol precursor of cholesterol (surro-
gate marker of cholesterol synthesis), was inversely asso-
ciated with campesterol and sitosterol in serum (as
ratios to cholesterol) (r = −0.575 and r = −0.697, p =
0.025 and 0.004, respectively) (Fig. 2a). Furthermore, the
stone cholestanol proportion was positively related to
the concentration of serum bile acids (Fig. 2b).
In the patients with CS, the surrogate sterol markers
of cholesterol absorption cholestanol, campesterol and
sitosterol were almost consistently positively interrelated
in serum and gallstones, being most evident between
serum cholestanol/cholesterol –ratio and the stone
proportions of the three surrogate markers of absorption
(r-range: +0.673–+0.727, p < 0.03 for each) (Fig. 2c).
Serum cholestanol/cholesterol ratio reflected also those
of campesterol and sitosterol in serum. Lathosterol/chol-
esterol –ratio was inversely related to that of cholestanol
in serum (r = −0.633, p = 0.036). Furthermore, ratios to
cholesterol of serum and gallstone lathosterol were posi-
tively interrelated (r = +0.847, p = 0.001).
Discussion
The main new results of the present study were that: (I)
BPS and CS subgroups had enhanced cholesterol synthesis,
(II) in the BPS group, solely serum squalene of the surro-
gate markers of cholesterol synthesis was logically (in-
versely) related to those of cholesterol absorption, (III) the
children with CS had low absorption of cholesterol, (IV)
their homeostatic regulation of cholesterol metabolism was
intact and (V), in the CS group, serum non-cholesterol
sterols reflected their own proportions in the stone content.
Hepatic hypersecretion of biliary cholesterol with for-
mation of cholesterol crystals from cholesterol supersatu-
rated bile is considered to be the crucial phenomenon in
the pathogenesis of the CS [6]. In general, adult gallstone
patients (predominantly with CS) have high synthesis of
cholesterol parallel to increased biliary output of choles-
terol, but relatively low intestinal cholesterol absorption,
indicating enhanced whole-body sterol clearance [25]. Op-
posite to the clinical picture of the CS patients, the sub-
jects with BPS are frequently associated with chronic
haemolytic disorders, in which increased biliary excretion
of bilirubin may lead to calcium bilirubinate precipitation
serving a nucleation core for BPS [26]. Previous data indi-
cate that certain variants of the gene encoding the hepato-
biliary sterol hemi-transporter ABCG8 and the Gilbert
syndrome-associated UGT1A1 variant are related to
increased risk of gallstones suggesting that increased
biliary secretions of cholesterol and bilirubin are crucial in
the stone pathogenesis [27–29]. The results of the present
study showed that the proportions of the serum surrogate
markers of cholesterol synthesis were consistently elevated
in the children with BPS and CS compared to the control
values. These findings are parallel to that reported in a
large series of adult gallstone patients, in whom choles-
terol synthesis seemed to be equal between CS and BPS
groups [5]. Altogether these data indicate that both stone
subclasses in children are characterized by enhanced syn-
thesis of cholesterol and, consequently, increased biliary
secretion of cholesterol, thus, sharing a common etio-
pathogenetic factor in the stone formation. The results of
the present study also indicate, that CS children with high
surrogate markers of cholesterol synthesis have low those
of cholesterol absorption, and that these variables are
logically inversely related to each other. Furthermore, in
the CS group, the higher the ISO-BMI the lower was the
serum cholestanol ratio, and, thus, intestinal cholesterol
absorption. These findings suggest, first, that cholesterol
metabolism in the children with CS resembles that of
adult gallstone patients, secondly, homeostasis of choles-
terol metabolism is undisturbed among children with CS
and, thirdly, overweight together with low intestinal chol-
esterol absorption are associated with risk of CS in chil-
dren equally to that described in adults [25]. Interestingly,
studies with experimental animals suggest that in most
CS-prone humans, the small intestine is flooded continu-
ously with an abundance of liver-secreted cholesterol mol-
ecules via bile [30]. Opposite to that found among the CS-
subjects, in the BPS group, of the relative cholesterol syn-
thesis marker, solely the early precursor of cholesterol,
squalene, inversely reflected those of absorption suggest-
ing that in the BPS group normal cholesterol homeostasis
was deteriorated. Comparison between the pediatric BPS
and CS groups could be strengthened by expanding the
number of patients in these subgroups.
The results of our previous and the present study sup-
port the view that solely the history of parenteral nutrition
does not explain high proportions of campesterol and si-
tosterol in BPS [7]. Interestingly, high cholesterol synthesis
is associated with increased biliary cholesterol secretion
paralleling also increased biliary secretion of sitosterol and
campesterol [31]. In the BPS group, the serum propor-
tions of the two most abundant plant sterols – campes-
terol and sitosterol – were equal to those of controls
supporting the view, that, first, intestinal cholesterol ab-
sorption was normal in the BPS group, and, secondly, the
high proportions of plant sterols in the stones of the BPS
group could at least partly be explained by increased
biliary secretion of cholesterol.
Plant sterols, especially stigmasterol, have been shown
to antagonize nuclear farnesoid receptor X -mediated bile
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Fig. 2 a Correlation between serum ratios to cholesterol of squalene and sitosterol in the cholecystectomized subjects with black pigment stones.
r = Spearman rank correlation coefficient. b Correlation between stone cholestanol proportion and serum bile acids in the cholecystectomized subjects
with black pigment stones. r = Spearman rank correlation coefficient. c Correlation between ratios to cholesterol of stone sitosterol and serum
cholestanol in the cholesterol stone subgroup. r = Spearman rank correlation coefficient
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acid homeostasis in hepatocytes and associate with hep-
atocyte damage [32, 33]. From this point of view, it was in-
teresting to note in the present study that serum
stigmasterol/cholesterol was even below that of controls
in both stone subclasses making it unobvious that serum
stigmasterol interferes with stone pathogenesis. However,
stone stigmasterol proportion in the BPS group was high
compared to that of CS putatively due to its high biliary
secretion. Overall, high proportions of phytosterols (cam-
pesterol, sitosterol, avenasterol and stigmasterol) in the
stones of the BPS group suggest that, first, the gallstone
disease with respect to BPS differs from that of adults,
and, secondly, phytosterols may be related to the forma-
tion of pediatric BPS.
The present study indicated that the children with
BPS were characterized by high serum and stone pro-
portions of cholestanol. Cholestanol is a noncholesterol
sterol metabolite of cholesterol that serves as a surrogate
marker of cholesterol absorption under normal physio-
logical conditions and reflects sensitively cholestasis in
primary biliary cirrhosis and biliary atresia [34, 35]. Par-
alleling these findings, in BPS patients of the present
study, serum bile acid concentration and stone compos-
ition of cholestanol (but not plant sterols) were posi-
tively interrelated suggesting that high cholestanol
proportions in the stones of the BPS group could partly
be explained by cholestasis. Cholesterol precursors have
been associated with some disorders in human subjects,
such as squalene in cardiovascular diseases, desmosterol
in steatohepatitis and 7-dehydrocholesterol in Smith-
Lemli-Opitz syndrome [36–38]. In addition, subjects af-
fected by autosomally inherited disease phytosterolemia
are characterized by very high levels of phytosterols in
serum and tissues [39]. So far, serum cholestanol and
phytosterols have not been related to the gallstone dis-
ease in the absence of parenteral nutrition. In the
present study, several subjects in the BPS group had a
disease associated with haemolysis, but haemolysis itself
had no influence on serum cholestanol or plant sterol
proportions. Overall, high stone and serum proportions
cholestanol and plant sterols together with deteriorated
cholesterol homeostasis (as evaluated by the non-
cholesterol sterol surrogate markers) support the views
that, first, BPS patients have had at least in their history
a high biliary secretion of these sterols, and, secondly,
some so far unidentified factors may lie behind accumu-
lation of these non-cholesterol sterols in the stones and
serum of the BPS patients. In the pathogenesis of BPS,
also several factors in the gallbladder mucosa play cru-
cial roles [40, 41].
Conclusions
In conclusion, the gallstones of the pediatric BPS group
are characterized by high proportions of plant sterols and
cholestanol, of which solely the latter one reflects chole-
stasis. This findings support the view that plant sterols
may be involved in the pathogenesis of BPS. Further
research is needed to evaluate whether screening for high
serum cholestanol ratios could be helpful in early detec-
tion of gallstones at high risk groups. Cholesterol homeo-
stasis with increased cholesterol synthesis and low
cholesterol absorption together with high ISO-BMI in the
pediatric CS group resembles those risk factors associated
with CS disease described in adults and with the metabolic
syndrome. Identification of this clinical connection gives
tools to decrease the risk for the pediatric CS disease.
High cholesterol synthesis in both stone subclasses sup-
port the view of increased biliary cholesterol secretion,
which consequently enables cholesterol supersaturation in
bile. This phenomenon displays that these two stone sub-
classes share a similarity with this respect in the pathogen-
esis of gallstone formation.
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